Agile Therapeutics Inc Shares Fall 3.0% Below Previous 52-Week Low - Market Mover
The shares fell 3.0% lower than its previous 52-week low of $0.39, with trading volume higher than its 30 day average
Jan 15, 2022 by Kwhen Finance Editors
Agile Therapeutics Inc (AGRX) shares closed 3.0% lower than its previous 52 week low, giving the company a market cap of $48M. The stock is currently down 18.6% year-to-date, down 86.0% over the past 12 months, and down 84.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%.
Trading Activity
- Trading volume this week was 77.6% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
- The stock closed at 3.9% lower than its 5-day moving average, 20.4% lower than its 20-day moving average, and 48.5% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Agile Therapeutics Inc | -4.5 | -18.6 | -86.0 | -89.1 | 4.8 |
| Dow Jones Industrial Average | -0.6 | -1.2 | 17.8 | -3.1 | 22.0 |
| S&P 500 Index | 0.0 | -2.2 | 24.4 | -3.9 | 26.9 |
| Health Care | -0.2 | -5.7 | 12.9 | -6.8 | 19.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 1575.9%
- The company's stock price performance over the past 12 months lags the peer average by 1400.9%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Agile Therapeutics Inc | AGRX | 0 | -18.6 | -86.0 | -89.1 | 4.8 |
| Peer Avg | N/A | 15.6 | -1.1 | -5.7 | -28.7 | 109.7 |
| Johnson & Johnson | JNJ | 24.7 | -1.9 | 7.1 | -5.2 | 13.3 |
| Pfizer Inc. | PFE | 16.1 | -6.9 | 55.4 | -10.7 | 69.8 |
| Merck & Co Inc | MRK | 28.6 | 6.2 | 2.6 | -9.9 | 447.3 |
| Antares Pharma Inc | ATRS | 9.3 | 0 | -17.7 | -30.4 | 13.5 |
| TherapeuticsMD Inc | TXMD | -0.9 | -2.9 | -76.0 | -87.4 | 4.6 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: